Literature DB >> 12597260

Ginkgo biloba for the prevention and treatment of cardiovascular disease: a review of the literature.

Gail B Mahady1.   

Abstract

Results from clinical trials demonstrate that standardized leaf extracts of Ginkgo biloba (SGB extract) reduce the symptoms of age-associated memory impairment and dementia, including Alzheimer's disease, and may be of benefit in treating intermittent claudication. In addition, preliminary results suggest that SGB extract may be useful in preventing and treating cardiovascular disease (CVD). particularly ischemic cardiac syndrome. Since many patients with cardiovascular disease are already taking anticoagulants and antiplatelet drugs, self-medication with SGB extract is not recommended without the advice of their physician. Although SGB extracts look promising for preventing and treating CVD, well-controlled clinical trials are needed before clinical recommendations can be made.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12597260     DOI: 10.1097/00005082-200207000-00004

Source DB:  PubMed          Journal:  J Cardiovasc Nurs        ISSN: 0889-4655            Impact factor:   2.083


  18 in total

1.  Protection against beta-amyloid induced abnormal synaptic function and cell death by Ginkgolide J.

Authors:  Ottavio Vitolo; Bing Gong; Zixuan Cao; Hideki Ishii; Stanislav Jaracz; Koji Nakanishi; Ottavio Arancio; Sergei V Dzyuba; Roger Lefort; Michael Shelanski
Journal:  Neurobiol Aging       Date:  2007-07-20       Impact factor: 4.673

2.  Molecular mechanisms underlying the cholesterol-lowering effect of Ginkgo biloba extract in hepatocytes: a comparative study with lovastatin.

Authors:  Zuo-quan Xie; Gai Liang; Lu Zhang; Qi Wang; Yi Qu; Yang Gao; Li-bo Lin; Sai Ye; Ji Zhang; Hui Wang; Guo-ping Zhao; Qing-hua Zhang
Journal:  Acta Pharmacol Sin       Date:  2009-08-24       Impact factor: 6.150

3.  Effects of standardized extract of Ginkgo biloba leaves EGb761 on mitochondrial functions: mechanism(s) of action and dependence on the source of mitochondria and respiratory substrate.

Authors:  Giedre Baliutyte; Sonata Trumbeckaite; Rasa Baniene; Vilmante Borutaite; Adolfas Toleikis
Journal:  J Bioenerg Biomembr       Date:  2014-11-14       Impact factor: 2.945

Review 4.  Herb-drug interactions: a literature review.

Authors:  Zeping Hu; Xiaoxia Yang; Paul Chi Lui Ho; Sui Yung Chan; Paul Wan Sia Heng; Eli Chan; Wei Duan; Hwee Ling Koh; Shufeng Zhou
Journal:  Drugs       Date:  2005       Impact factor: 9.546

5.  Effect of Ginkgo biloba on blood pressure and incidence of hypertension in elderly men and women.

Authors:  Tina E Brinkley; James F Lovato; Alice M Arnold; Curt D Furberg; Lewis H Kuller; Gregory L Burke; Richard L Nahin; Oscar L Lopez; Sevil Yasar; Jeff D Williamson
Journal:  Am J Hypertens       Date:  2010-02-18       Impact factor: 2.689

6.  Does Ginkgo biloba reduce the risk of cardiovascular events?

Authors:  Lewis H Kuller; Diane G Ives; Annette L Fitzpatrick; Michelle C Carlson; Carla Mercado; Oscar L Lopez; Gregory L Burke; Curt D Furberg; Steven T DeKosky
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2009-11-24

7.  Comparison of the design differences between the Ginkgo Evaluation of Memory study and the GuidAge study.

Authors:  J D Williamson; B Vellas; C Furberg; R Nahin; S T Dekosky
Journal:  J Nutr Health Aging       Date:  2008-01       Impact factor: 4.075

8.  Ginkgo biloba for prevention of dementia: a randomized controlled trial.

Authors:  Steven T DeKosky; Jeff D Williamson; Annette L Fitzpatrick; Richard A Kronmal; Diane G Ives; Judith A Saxton; Oscar L Lopez; Gregory Burke; Michelle C Carlson; Linda P Fried; Lewis H Kuller; John A Robbins; Russell P Tracy; Nancy F Woolard; Leslie Dunn; Beth E Snitz; Richard L Nahin; Curt D Furberg
Journal:  JAMA       Date:  2008-11-19       Impact factor: 56.272

Review 9.  The bleomycin animal model: a useful tool to investigate treatment options for idiopathic pulmonary fibrosis?

Authors:  Antje Moeller; Kjetil Ask; David Warburton; Jack Gauldie; Martin Kolb
Journal:  Int J Biochem Cell Biol       Date:  2007-08-30       Impact factor: 5.085

10.  Mechanism of Huo-Xue-Qu-Yu Formula in Treating Nonalcoholic Hepatic Steatosis by Regulating Lipid Metabolism and Oxidative Stress in Rats.

Authors:  Bin Cheng; Ai-Zhen Zhou; Wen Ge; Xiao-Min Yao; Juan Wang
Journal:  Evid Based Complement Alternat Med       Date:  2021-04-29       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.